268 related articles for article (PubMed ID: 22027718)
1. Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons.
Bonaventura K; Sonntag S; Kleber FX
EuroIntervention; 2011 May; 7 Suppl K():K106-11. PubMed ID: 22027718
[TBL] [Abstract][Full Text] [Related]
2. In-stent restenosis: the gold standard has changed.
Chin K
EuroIntervention; 2011 May; 7 Suppl K():K43-6. PubMed ID: 22027726
[TBL] [Abstract][Full Text] [Related]
3. PCI in small vessels: the case for a drug-coated balloon based intervention.
Zeymer U; Scheller B
EuroIntervention; 2011 May; 7 Suppl K():K57-60. PubMed ID: 22027729
[No Abstract] [Full Text] [Related]
4. Lesions in small coronary vessels disease: should drug-coated balloons replace drug-eluting stents as the treatment of choice?
Byrne RA; Kastrati A
EuroIntervention; 2011 May; 7 Suppl K():K47-52. PubMed ID: 22027727
[TBL] [Abstract][Full Text] [Related]
5. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
6. How to use the drug-eluting balloon: recommendations by the German consensus group.
Kleber FX; Mathey DG; Rittger H; Scheller B;
EuroIntervention; 2011 May; 7 Suppl K():K125-8. PubMed ID: 22027722
[No Abstract] [Full Text] [Related]
7. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
[TBL] [Abstract][Full Text] [Related]
8. Local drug delivery - the early Berlin experience: single drug administration versus sustained release.
Speck U; Scheller B; Rutsch W; Laule M; Stangl V
EuroIntervention; 2011 May; 7 Suppl K():K17-22. PubMed ID: 22027723
[TBL] [Abstract][Full Text] [Related]
9. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
11. Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study.
Beijk MA; Klomp M; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; Tijssen JG; Piek JJ; de Winter RJ
Catheter Cardiovasc Interv; 2011 Aug; 78(2):189-95. PubMed ID: 21542109
[TBL] [Abstract][Full Text] [Related]
12. Aneurysm formation after drug-eluting balloon treatment of drug-eluting in-stent restenosis: first case report.
Vassilev D; Hazan M; Dean L
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1223-6. PubMed ID: 22419657
[TBL] [Abstract][Full Text] [Related]
13. New technologies in percutaneous coronary interventions: drug-coated balloons.
Kleber FX; Scheller B; Serruys PW
EuroIntervention; 2011 May; 7 Suppl K():K7. PubMed ID: 22027732
[No Abstract] [Full Text] [Related]
14. Rationale and design of the randomized, multicenter EREMUS trial, a study that investigates how to achieve low restenosis and early reendothelialization after percutaneous coronary interventions.
Cortese B; Danzi GB; Pitì A; Severi S; Limbruno U
Catheter Cardiovasc Interv; 2011 Jul; 78(1):32-7. PubMed ID: 21413116
[TBL] [Abstract][Full Text] [Related]
15. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
16. The excel stent: a good DES, but can we really stop clopidogrel after 6 months?
Margolis JR
JACC Cardiovasc Interv; 2009 Apr; 2(4):310-1. PubMed ID: 19463442
[No Abstract] [Full Text] [Related]
17. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
Spinler SA
Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
[TBL] [Abstract][Full Text] [Related]
18. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents.
Baber U; Akhter M; Kothari S; Sharma SK; Kini A
J Invasive Cardiol; 2010 Feb; 22(2):80-3. PubMed ID: 20124594
[TBL] [Abstract][Full Text] [Related]
20. Enhanced platelet inhibition by adjunctive cilostazol to dual antiplatelet therapy after drug-eluting stent implantation for complex lesions.
Jeong YH; Park Y; Kim IS; Yun SE; Kang MK; Hwang SJ; Kwak CH; Hwang JY
Thromb Haemost; 2010 Dec; 104(6):1286-9. PubMed ID: 20838742
[No Abstract] [Full Text] [Related]
[Next] [New Search]
